Navigation Links
Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
Date:12/5/2008

d its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products and services; the successful development of diagnostic and therapeutic products applying Rosetta's technology,; Rosetta's ability to obtain regulatory clearances or approvals for products, as may be required under applicable laws; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; the ability to obtain coverage and payment from health plans and payers for diagnostic and therapeutic products applying Rosetta's technology and Rosetta's short operating history; as well as those risks more fully discussed under "Key Information - Risk Factors" in Rosetta's Annual Report on Form 20-F for the year ended December 31, 2007 on file with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of today and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.

    CONSOLIDATED STATEMENTS OF OPERATIONS
    U.S. dollars in thousands (except share and per share data)

                                        Nine months         Three months
                                     ended September 30,  ended September 30,
                                     2008          2007   2008          2007
                                         Unaudited             Unaudited

    Revenues                    $ 705            $ -       $ 705         $ -

    Cost of revenues              360              -         360           -

    Gross Profit                $ 345            $ -       $ 345         $ -

   
'/>"/>
SOURCE  Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 

Related biology technology :

1. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
2. /C O R R E C T I O N -- Rosetta Genomics Ltd/
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
4. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
5. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
6. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
7. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
8. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
9. Rosetta Genomics Reports Second Quarter 2008 Financial Results
10. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
11. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today anno
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...n collaboration with the Chinese Academy of Scienc...tation of molecules on a fixed surface to understa...rotor-based machinery at nanoscale level. , The...ch play an important part in machines like electri...logy at the atomic scale is to replicate this prop...
...RCROSS, Ga., May 27 Immucor, Inc. (Nasdaq: BLUD...ent-reagent systems to the blood transfusion indus...r agreement with Alverno Clinical Laboratories, LL... integrated delivery systems in the nation, servin...r the agreement, Alverno is standardizing pre-tran...
...rst clinical study evaluating DUROS(R) continuous ...diabetes , , HAYWARD, Calif., May 27 Intarcia Th...linical data from a phase 1b study of ITCA 650 (DU...reatment of type 2 diabetes as a late-breaker at t...ciation in New Orleans, LA (June 5-9, 2009). The s...
Other Biology Technology:Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement 2Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 2Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions 3
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Sakayu Shimizu of Kyoto University recipient of 2009 Enzyme Engineering Award 9960 1Sakayu Shimizu of Kyoto University recipient of 2009 Enzyme Engineering Award 9960 2Regulatory role of key molecule discovered at Hebrew U 9958 1MedTrust Online Surpasses 5 000 Registered Users and Adds Dr Henry Friedman to Oncology Advisory Board 14120 1MedTrust Online Surpasses 5 000 Registered Users and Adds Dr Henry Friedman to Oncology Advisory Board 14120 2
... scientists, including a team from The University ... (IMB), is a step closer to the next generation of...comprehensive analysis of the human and mouse tran...nd IMB researcher Professor David Hume said transc... the genome by a cell at any given time. , "Esse...
...rnational Rice Research Institute (IRRI) is workin...South East Asian Nations (ASEAN) to develop a seri... in the region. , When implemented, the indicators...e environmental impact of its rice production with...blems or improve on existing practices. It,s the f...
... isn,t really that sluggish after all. So says the...e creature,s behavior in the wild, which was just ...l Bulletin. , The new research is significant bec...dibranch mollusc species found in the shallow nort...of the how the brain controls behavior, a field kn...
Other Biology News:Learning the language of DNA 2A cleaner, greener rice industry 2The secret lives of sea slugs 2
cAMP Competitive immunoassay Assay Kit, HTRF from Cisbio
...in filters allow for the rapid isolation of DNA fr...ice in the spin filter, centrifuge for 3 minutes, ...s no need to melt agarose or use any special buff...ange, primer removal from PCR reactions, and remov...
Human Atherosclerosis Antibody Array I Kit, ChemiArray, 20 cytokines per membrane from CHEMICON
High-Binding EIA 96 Well Strip Plates from Cayman Chemical
Biology Products: